Search NASA⌕ Search

SEARCH · Search NASA

Results for “DOSIMETRY”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 145 records · Page 8
All sourcesNASA NTRSDOE OSTI
DOE OSTI2024

IER-484 CED3b Report: AFRRI ER1 Dosimetry Characterization

This report presents the preliminary work for IER 484, the characterization of the leakage radia tion field from the TRIGA reactor at the Armed Forces Radiobiology Research Institute (AFRRI). The purpose of the dose characterization is to establish the reference dose needed to execute a NAD inter-comparison exercise. During the week of August 20th, a team from Lawrence Livermore National Laboratory (LLNL), Sandia National Laboratory (SNL), and Institut de Radioprotection et de Sûreté Nucléaire (IRSN) performed various measurements in AFRRI’s TRIGA ER1 (Exposure Room 1) with Passive Neutron Spectrometer (PNS) spheres and nuclear accident dosimeters (NADs) mounted on Bottle Manikin Absorption (BOMAB) phantoms (to simulate doses received by people) and additional NADs mounted on aluminum plates (to simulate doses in free air). Without Atomic Weapons Establishment (AWE), LLNL became responsible for measuring the neutron spectrum using PNS spheres. SNL is responsible for providing photon dose data. LLNL, SNL, and IRSN each deployed their own NADs, which will be compared to the reference dose measured. Final characterization of the dose field based on analyzed data will be presented in the CED4a report.

42 ENGINEERING↗
DOE OSTI2024

IER-484 CED4a Report: AFRRI ER1 Dosimetry Characterization

This report presents an analytical function as the reference neutron and photon dose (normalized to an ion chamber integral) for future nuclear accident dosimeter (NAD) exercise at the Armed Forces Radiobiology Research Institute (AFRRI). Various dosimeters and equipment were positioned within exposure room 1 (ER1) and irradiated using a 1.1 MW Training, Research, Isotope, General Atomics (TRIGA) Mark-F nuclear reactor. An ion chamber located in ER1 was used as a normalization factor in Equation 2. This allows for a quick calculation of neutron and photon dose based on the ion chamber data. Currently, AFRRI is in preparation to host a NAD exercise this summer.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2025

Updated Results of the Nuclear Accident Dosimetry Intercomparison at the Armed Forces Radiobiology Research Institute’s TRIGA Reactor (IER-602 CED-4a Report)

The IER-602 3b document (Angus, et al. 2024) reported the initial, 24-hour results of the international nuclear accident intercomparison, which took place at the Armed Forces Radiobiological Research Institute during June 24-28, 2024. This report provides updated results and further analysis of the intercomparison.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2022

Positron Emission Intensity in the Decay of 86 gY for Use in Dosimetry Studies

The β + -emitting radionuclide 86 gY (t 1/2 = 14.7 h) forms a matched-pair with the β – -emitting therapeutic radionuclide 90Y (t 1/2 = 2.7 d) for theranostic application in medicine. This approach demands a precise knowledge of the positron emission probability of the PET nuclide which was until recently rather uncertain for 86 gY. In this work, an 86 gY source of high radionuclidic purity was prepared and a direct measurement of the positron emission intensity per 100 decay of the parent (hereafter “positron emission intensity”) was performed using high-resolution HPGe detector γ-ray spectroscopy. The electron capture intensity was also determined as an additional check by measuring the K α and K β X-rays of energies 14.1 and 15.8 keV, respectively, using a low energy HPGe detector. From those measurements, normalized values of 27.2 ± 2.0% for β + -emission and 72.8 ± 2.0% for EC were obtained. These results are in excellent agreement with values recently reported in the literature based on a detailed decay scheme study.

61 RADIATION PROTECTION AND DOSIMETRY↗
NASA NTRS2002

Passive dosimetry aboard the Mir Orbital Station: external measurements

This paper reports results from the first measurements made on the exterior of a LEO spacecraft of mean dose equivalent rate and average quality factor as functions of shielding depth for shielding less than 1 g/cm2 Al equivalent. Two sets of measurements were made on the outside of the Mir Orbital Station; one near solar maximum in June 1991 and one near solar minimum in 1997. Absorbed dose was measured using stacks of TLDs. LET spectrum from charged particles of LET infinity H2O > o r= 5keV/micrometers was measured using stacks of CR-39 PNTDs. Results from the TLD and PNTD measurements at a given shielding depth were combined to yield mean total dose rate, mean dose equivalent rate, and average quality factor. Measurements made near solar maximum tend to be greater than those made during solar minimum. Both mean dose rate and mean dose equivalent rate decrease by nearly four orders of magnitude within the first g/cm2 shielding illustrating the attenuation of both trapped electrons and low-energy trapped protons. In order to overcome problems with detector saturation after standard chemical processing, measurement of LET spectrum in the least shielded CR-39 PNTD layer (0.005 g/cm2 Al) was carried out using an atomic force microscope. c2002 Elsevier Science Ltd. All rights reserved.

manned↗
NASA NTRS2002

Passive dosimetry aboard the Mir Orbital Station: internal measurements

Passive radiation dosimeters were exposed aboard the Mir Orbital Station over a substantial portion of the solar cycle in order to measure the change in dose and dose equivalent rates as a function of time. During solar minimum, simultaneous measurements of the radiation environment throughout the habitable volume of the Mir were made using passive dosimeters in order to investigate the effect of localized shielding on dose and dose equivalent. The passive dosimeters consisted of a combination of thermoluminescent detectors to measure absorbed dose and CR-39 PNTDs to measure the linear energy transfer (LET) spectrum from charged particles of LET infinity H2O > or = 5 keV/micrometers. Results from the two detector types were then combined to yield mean total dose rate, mean dose equivalent rate, and average quality factor. Contrary to expectations, both dose and dose equivalent rates measured during May-October 1991 near solar maximum were higher than similar measurements carried out in 1996-1997 during solar minimum. The elevated dose and dose equivalent rates measured in 1991 were probably due to a combination of intense solar activity, including a large solar particle event on 9 June 1991, and the temporary trapped radiation belt created in the slot region by the solar particle event and ensuing magnetic storm of 24 March 1991. During solar minimum, mean dose and dose equivalent rates were found to vary by factors of 1.55 and 1.37, respectively, between different locations through the interior of Mir. More heavily shielded locations tended to yield lower total dose and dose equivalent rates, but higher average quality factor than did more lightly shielding locations. However, other factors such as changes in the immediate shielding environment surrounding a given detector location, changes in the orientation of the Mir relative to its velocity vector, and changes in the altitude of the station also contributed to the variation. Proton and neutron-induced target fragment secondaries, not primary galactic cosmic rays, were found to dominate the LET spectrum above 100 keV/micrometers. This indicates that in low earth orbit, trapped protons in the South Atlantic Anomaly are responsible for the major fraction of the total dose equivalent. c2002 Elsevier Science Ltd. All rights reserved.

NASA Experiment Number 9401620↗
NASA NTRS1999

Application of real-time radiation dosimetry using a new silicon LET sensor

A new type of real-time radiation monitoring device, RRMD-III, consisting of three double-sided silicon strip detectors (DSSDs), has been developed and tested on-board the Space Shuttle mission STS-84. The test succeeded in measuring the linear energy transfer (LET) distribution over the range of 0.2 keV/micrometer to 600 keV/micrometer for 178 h. The Shuttle cruised at an altitude of 300 to 400 km and an inclination angle of 51.6 degrees for 221.3 h, which is equivalent to the International Space Station orbit. The LET distribution obtained for particles was investigated by separating it into galactic cosmic ray (GCR) particles and trapped particles in the South Atlantic Anomaly (SAA) region. The result shows that the contribution in dose-equivalent due to GCR particles is almost equal to that from trapped particles. The total absorbed dose rate during the mission was 0.611 mGy/day; the effective quality factor, 1.64; and the dose equivalent rate, 0.998 mSv/day. The average absorbed dose rates are 0.158 mGy/min for GCR particles and 3.67 mGy/min for trapped particles. The effective quality factors are 2.48 for GCR particles and 1.19 for trapped particles. The absorbed doses obtained by the RRMD-III and a conventional method using TLD (Mg(2)SiO(4)), which was placed around the RRMD-III were compared. It was found that the TLDs showed a lower efficiency, just 58% of absorbed dose registered by the RRMD-III.

NASA Discipline Radiation Health↗
DOE OSTI2024

Correlation of As-read and As-run Dosimetry Data

The Nuclear Science Users Facilities (NSUF) is responsible for the coordination of experiments conducted in Advanced Test Reactor (ATR) by Universities and other outside organizations. Completion of the experiment and data reporting process is long and expensive. As such, it is expected that targets for temperature and neutron dosage are met. Simulations of expected reactor performance under specific conditions to meet these targets are critical for this process. However, it is not often that these reports are correlated with the data produced by monitors in ATR. This project aims to correlate simulation and read data from experiments in ATR to gauge uncertainty.

22 GENERAL STUDIES OF NUCLEAR REACTORS↗
DOE OSTI2020

Neutron heating assessment in Minerve reactor by using alanine/ESR dosimetry

In the framework of the ICERR (International Center based on Research Reactors) project, the effect of neutron/gamma irradiation on material and dosimeters has been studied. In this work, we explore the alanine dose-response in the core of the MINERVE research reactor at the CEA Cadarache and we investigate the neutron heating effects in order to evaluate alanine neutron sensitivity. The measured dose of the alanine detector in the mixed gamma-neutron field was estimated by electron spin resonance spectrometry (ESR) with reference to an absorbed dose in water from a 60 Co gamma-ray beam. The experimental sources of uncertainties were reduced by using the optimum conditions of charged-particle equilibrium (CPE), obtained by introducing alanine dosimeters into the aluminum pillbox. Cavity correction factors and dose components were evaluated by the Monte Carlo code MCNP. The calculation showed an underestimated neutron dose with a (C/E) value of about 0.993 +/- 10.83%(k = 1). Results indicate that the fast neutron dose, mainly due to elastic neutron scattering on hydrogen nuclei, represents about 70% of the total dose, while the gamma dose was found to be around 45% of the neutron dose. Additionally, the neutron relative efficiency (REn) to 60 Co gamma-radiation was estimated to be 0.544 +/- 8%(k = 1).

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗
DOE OSTI2021

Translating dosimetry of Dibenzo[ def,p ]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling

We report that Dibenzo[def,p]chrysene (DBC) is an environmental polycyclic aromatic hydrocarbon (PAH) that causes tumors in mice and has been classified as a probable human carcinogen by the International Agency for Research on Cancer. Animal toxicity studies often utilize higher doses than are found in relevant human exposures. Additionally, like many PAHs, DBC requires metabolic bioactivation to form the ultimate toxicant, and species differences in DBC and DBC metabolite metabolism have been observed. To understand the implications of dose and species differences, a physiologically based pharmacokinetic model (PBPK) for DBC and major metabolites was developed in mice and humans. Metabolism parameters used in the model were obtained from experimental in vitro metabolism assays using mice and human hepatic microsomes. PBPK model simulations were evaluated against mice dosed with 15 mg/kg DBC by oral gavage and human volunteers orally microdosed with 29 ng of DBC. DBC and its primary metabolite DBC-11,12-diol were measured in blood of mice and humans, while in urine, the majority of DBC metabolites were obeserved as conjugated DBC-11,12-diol, conjugated DBC tetrols, and unconjugated DBC tetrols. The PBPK model was able to predict the time course concentrations of DBC, DBC-11,12-diol, and other DBC metabolites in blood and urine of human volunteers and mice with reasonable accuracy. Agreement between model simulations and measured pharmacokinetic data in mice and human studies demonstrate the success and versatility of our model for interspecies extrapolation and applicability for different doses. Furthermore, our simulations show that internal dose metrics used for risk assessment do not necessarily scale allometrically, and that PBPK modeling provides a reliable approach to appropriately account for interspecies differences in metabolism and physiology.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2025

A physiologically based pharmacokinetic (PBPK) model to align dosimetry of the isobutyl metabolic series in rats and humans

Here, we developed a physiologically based pharmacokinetic (PBPK) model in rats and humans for the isobutyl metabolic series including isobutyl acetate, isobutanol, isobutyraldehyde, and isobutyric acid. Chemical manufactures routinely use these compounds as solvents, for chemical synthesis, as potential biofuels, de-icing fluids, and additives for food and/or fragrance in consumer products. Human exposure to isobutyl compounds can occur through inhalation or oral routes. We previously developed a PBPK model for the propyl metabolic series and utilized it as a framework to create the isobutyl PBPK model due to the chemical similarities between the two series. To support model development, we measured in vitro metabolism of isobutyl acetate in rat and human blood and liver S9 fractions. Compared to rats, humans demonstrated faster isobutyl acetate hydrolysis in liver S9 fractions, while the hydrolysis rates in blood were similar between the two species. We used concentrations of isobutyl compounds measured in air and blood from rats exposed to isobutyl acetate and isobutanol as well as other published data to further parameterize the model. Following exposure to either isobutyl acetate or isobutanol, we observed isobutanol concentrations highest among the isobutyl compounds in the blood of rats. Overall, the model accurately predicts measured time course concentrations of isobutyl acetate, isobutanol, and isobutyric acid in available data in rats and humans. Sensitivity analyses identified alveolar ventilation rates, isobutyl metabolism rates, and cardiac output as the most sensitive parameters affecting concentrations of isobutyl compounds in blood. The isobutyl PBPK model enables comparisons of internal dose metrics across various isobutyl compound exposures and species and allows for calculation of equivalent external exposures that result in the same dose metric. Regulators can employ this PBPK model to predict and align internal dose metrics of isobutyl compounds for risk assessment purposes.

2-methyl-1-propanol↗